Software Alternatives, Accelerators & Startups

Fundra VS Donate and Discuss

Compare Fundra VS Donate and Discuss and see what are their differences

Fundra logo Fundra

Fundra is a simple yet powerful fundraising platform that assists all sizes of nonprofit organizations in building trust with donors to increase donations.

Donate and Discuss logo Donate and Discuss

Offer your time in exchange for a donation to combat COVID
  • Fundra Landing page
    Landing page //
    2022-11-09
  • Donate and Discuss Landing page
    Landing page //
    2021-04-24

Fundra videos

STRAIN REVIEW: CRUNCH BERRIEZ BY THE FUNDRAISERS #oopzallberryz

More videos:

  • Review - OneCause | Virtual Fundraising Platform | eGuide Tech Allies Review

Donate and Discuss videos

No Donate and Discuss videos yet. You could help us improve this page by suggesting one.

+ Add video

Category Popularity

0-100% (relative to Fundra and Donate and Discuss)
Fundraising And Donation Management
Tech
0 0%
100% 100
Nonprofit CRM
100 100%
0% 0
Social Impact
0 0%
100% 100

User comments

Share your experience with using Fundra and Donate and Discuss. For example, how are they different and which one is better?
Log in or Post with

What are some alternatives?

When comparing Fundra and Donate and Discuss, you can also consider the following products

LenderKit - LenderKit is an advanced level crowdfunding solution that allows you to create and run your online investment business quickly.

Software Donation - Donate tools to enable remote work during COVID-19 outbreak

360MatchPro - 360MatchPro is an all-in-one fundraising and gift matching software that helps individual’s organization matches their pledge to their preferred cause if they are eligible.

Donation Pages by PayRequest - 0% Fee for your donation page to help during COVID-19!

Revv - Revv is a comprehensive fundraising software designed by a professional who contains all the core services and tools to make it a one-stop solution.

MineAMask - Donate spare CPU power to generate funds & fight COVID-19